Is the predictive value of systemic immune-inflammation index superior to traditional markers in ST-elevation myocardial infarction patients?
dc.authorid | 0000-0002-4297-1820 | en_US |
dc.authorid | 0000-0002-3183-5815 | en_US |
dc.authorid | 0000-0003-1784-3584 | en_US |
dc.contributor.author | Toprak, Kenan | |
dc.contributor.author | Kaplangöray, Mustafa | |
dc.contributor.author | Memioğlu, Tolga | |
dc.contributor.author | İnanır, Mehmet | |
dc.date.accessioned | 2023-07-24T13:17:20Z | |
dc.date.available | 2023-07-24T13:17:20Z | |
dc.date.issued | 2023 | en_US |
dc.department | BAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
dc.description.abstract | We read with great interest the recently published article ‘Systemic immune-inflammation index predicts in-hospital and long-term outcomes in patients with ST-segment elevation myocardial infarction’ by Öcal et al [1]. In their valuable, well designed, and presented research, the authors argue that the systemic immune-inflammation index (SII) is superior to traditional markers such as neutrophil-to-lymphocyte ratio (NLR) and platelet lymphocyte ratio (PLR) in predicting in-hospital adverse events in patients with ST-elevation myocardial infarction (STEMI) and they also claim that the discriminative value of SII in predicting in-hospital mortality in STEMI patients is higher than NLR; however, when the whole article is evaluated, we think that some methodological and literary issues should be reviewed by the authors. | en_US |
dc.identifier.citation | Toprak, K., Kaplangöray, M., Memioglu, T., & İnanir, M. (2023). Is the predictive value of systemic immune-inflammation index superior to traditional markers in ST-elevation myocardial infarction patients?. Coronary Artery Disease, 34(4), 281-281. | en_US |
dc.identifier.doi | 10.1097/MCA.0000000000001238 | |
dc.identifier.endpage | 281 | en_US |
dc.identifier.issn | 0954-6928 | |
dc.identifier.issn | 1473-5830 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 37102231 | en_US |
dc.identifier.scopus | 2-s2.0-85153904822 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 281 | en_US |
dc.identifier.uri | http://dx.doi.org/10.1097/MCA.0000000000001238 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12491/11348 | |
dc.identifier.volume | 34 | en_US |
dc.identifier.wos | WOS:000979476100007 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.institutionauthor | İnanır, Mehmet | |
dc.language.iso | en | en_US |
dc.publisher | Lippincott Williams & Wilkins | en_US |
dc.relation.ispartof | Coronary Artery Disease | en_US |
dc.relation.publicationcategory | Editöre Mektup - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | ST-elevation Myocardial Infarction (STEMI) | en_US |
dc.subject | NLR | en_US |
dc.subject | PLR | en_US |
dc.title | Is the predictive value of systemic immune-inflammation index superior to traditional markers in ST-elevation myocardial infarction patients? | en_US |
dc.type | Letter | en_US |